Mar 17, 2017 by Motley Fool StaffWhy Kite Pharma Stock Is Already Up 62% This YearThe potential to commercialize an entirely new approach to battling cancer is sparking a big rally in this biotech upstart.
Mar 16, 2017 by Motley Fool StaffThe Ins And Outs Of Shorting StocksHow shorting a stock works and why it’s such a dangerous move for investors to make.
Mar 16, 2017 by Motley Fool StaffWhy Portola Pharmaceuticals Stock Is Already Up an Eye-Popping 72% This YearThe potential to launch two blockbuster drugs in the next year is sparking optimism.
Mar 15, 2017 by Motley Fool StaffThe Beginning of a Stock Portfolio ExperimentA Motley Fool analyst reveals the stocks she’s buying right now.
Mar 15, 2017 by Motley Fool StaffWarren Buffett’s Big BetBy betting that hedge funds can’t beat the S&P 500, Warren Buffett is in the process of proving that individual investors can compete against the most sophisticated investors on Wall Street.
Mar 15, 2017 by Motley Fool StaffWhy Pacira Pharmaceuticals Stock Is Already Up 56% This YearGrowing use of this company's opioid alternative is fueling investor optimism.
Mar 15, 2017 by Motley Fool StaffWhy Exelixis Is Already Up 55% This YearA new cancer drug that's growing market share rapidly has been catapulting shares of this biotech higher.
Mar 14, 2017 by Motley Fool StaffWhy Exact Sciences Shares Are Already Up 65% in 2017Growing demand for its new colon cancer screening test is fueling investors' excitement.
Mar 14, 2017 by Motley Fool StaffWarren Buffett’s Plan to Beat the MarketThe Oracle of Omaha is waiting for the market to correct before piling into stocks.
Mar 13, 2017 by Motley Fool StaffA Lesson About Compound Returns From Warren BuffettOne of the best places to learn about the power of compounding returns is the first page of Warren Buffett’s annual letter.
Mar 13, 2017 by Motley Fool StaffBerkshire Hathaway, Dividends, and BuybacksWith Berkshire Hathaway’s annualized returns beginning to track the S&P 500, it isn’t unreasonable to think that the company could issue a dividend or start buying back stock at some point in the not-too-distant future.
Mar 12, 2017 by Motley Fool StaffAll About Shorting (or Not Shorting) Snap, Inc. StockThe bears might want to wait.
Mar 10, 2017 by Motley Fool StaffWhat Snap Inc Wants From DronesSnap’s apparent interest in drone technology is baffling to us for more than a few reasons. Here’s why.
Mar 10, 2017 by Motley Fool StaffWhy We're Not Crazy About Snap's SpectaclesSnap's Spectacles glasses offer a strange value proposition for customers.
Mar 8, 2017 by Motley Fool StaffA Look at Snap, Inc.'s IPOSnap has finally gone public, and the stock enjoyed two days of strong gains before it pulled back.
Mar 2, 2017 by Motley Fool StaffOil Demand To Increase Until 2040?BP is projecting that demand for oil will keep increasing into the mid-2040s -- where is this demand coming from, and how could it be met?
Mar 1, 2017 by Motley Fool Staff and Sean O'ReillyEurope Is Projected To Need Natural Gas, And The U.S. Can Supply ItEurope is set to lose a lot of its LNG production in the coming decades, and other countries will have to step in to meet that need.
Feb 28, 2017 by Motley Fool StaffFurther Growth In Permian Production Expected For 2017The Permian is booming and expected to keep on booming into 2017. Find out how investors might get in on this trend.
Feb 27, 2017 by Motley Fool StaffWhy Shopify Could Be A Great BuyE-commerce platform Shopify has seen incredible growth, and has a hugely impressive runway for even more.
